Secretariat of the Board of Governors
180 publications
Show
Sort by
-
- Journal Article
- open access
Exploration of Cytochrome P450-Related Interactions between Aflatoxin B1 and Tiamulin in Broiler Chickens
-
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial
-
Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database
-
- Journal Article
- open access
A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial
-
Sexual health in Belgian cervical cancer survivors: an exploratory qualitative study
-
- Journal Article
- open access
Endotoxin Translocation Is Increased in Broiler Chickens Fed a Fusarium Mycotoxin-Contaminated Diet
-
Digitalization and Resource Mobilization
-
- Journal Article
- A1
- open access
Qualitative risk assessment of homogeneity, stability, and residual concentrations of antimicrobials in medicated feed and drinking water in pig rearing
-
- Journal Article
- open access
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
-
- Journal Article
- open access
Reply to Z.R. McCaw et al
-
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors
-
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study
-
- Journal Article
- open access
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
-
- Journal Article
- open access
Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients
-
Being pushed out of the career : former teachers' reasons for leaving the profession